Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edgewise Therapeutics (EWTX) Net Income (2020 - 2026)

Edgewise Therapeutics has reported Net Income over the past 7 years, most recently at -$49.0 million for Q1 2026.

  • Quarterly results put Net Income at -$49.0 million for Q1 2026, down 20.14% from a year ago — trailing twelve months through Mar 2026 was -$176.0 million (down 20.48% YoY), and the annual figure for FY2025 was -$167.8 million, down 25.4%.
  • Net Income reached -$49.0 million in Q1 2026 per EWTX's latest filing, up from -$50.2 million in the prior quarter.
  • Across five years, Net Income topped out at -$14.7 million in Q1 2022 and bottomed at -$50.2 million in Q4 2025.
  • Median Net Income over the past 5 years was -$30.1 million (2023), compared with a mean of -$30.5 million.
  • The largest annual shift saw Net Income tumbled 115.11% in 2022 before it dropped 14.66% in 2025.
  • Over 5 years, Net Income stood at -$19.4 million in 2022, then tumbled by 55.26% to -$30.1 million in 2023, then plummeted by 31.58% to -$39.7 million in 2024, then decreased by 26.61% to -$50.2 million in 2025, then grew by 2.4% to -$49.0 million in 2026.
  • Business Quant data shows Net Income for EWTX at -$49.0 million in Q1 2026, -$50.2 million in Q4 2025, and -$40.7 million in Q3 2025.